Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder

Histopathology

Volumn 53, Issue 6, 2008, Pages 621-633

  Montironi, R ^a   Lopez Beltran, A ^b   Scarpelli, M ^a   Mazzucchelli, R ^a   Cheng, L ^c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Universidad de Cordoba   (Spain)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder metaplasia; Bladder neoplasms; Carcinoma in situ; Flat urothelial hyperplasia; Reactive urothelial atypia; Urothelial dysplasia; Urothelial papillary carcinoma

Indexed keywords

BENIGN TUMOR; BLADDER CANCER; CARCINOMA IN SITU; DYSPLASIA; HUMAN; METAPLASIA; MORPHOLOGY; PRIORITY JOURNAL; REVIEW; TUMOR CLASSIFICATION; UROTHELIUM;

HUMANS; HYPERPLASIA; PRECANCEROUS CONDITIONS; URINARY BLADDER; URINARY BLADDER NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 57049108644     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03025.x     Document Type: Review

References (66)

1. Mostofi FK, Sobin LH. Histologic typing of urinary bladder tumors. Geneva : World Health Organization, 1973.
2. Murphy WM, Beckwith JB, Farrow GM. Atlas of tumor pathology: tumors of the kidney, bladder, and related urinary structures. armed forces institute of pathology, 3rd series, Fascicle 11. Washington : AFIP, 1994.
3. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 1998 22 1435 1448.
4. Sauter G, Algaba F, Amin MB et al. Non-invasive urothelial tumours. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA eds. World Health Organization classification of tumours: pathology and genetics of tumours of the urinary system and male genital organ. Lyon : IARC Press, 2004, pp. 110 123.
5. Jost SP, Gosling JA, Dixon JS. The morphology of normal human bladder urothelium. J. Anat. 1989 167 103 115.
6. Epstein JI, Amin MB, Reuter VE. In Epstein JI ed. Urinary bladder biopsy interpretatio. Philadelphia : Lippincott Williams & Wilkins, 2004.
7. Montironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M. My approach to the morphological diagnosis of the urothelial neoplasms. J. Clin. Pathol. 2008 61 3 10.
8. Amin MB, Young RH. Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis of urothelial neoplasia. Semin. Diagn. Pathol. 1997 14 84 97.
9. Lopez-Beltran A, Cheng L, Andersson L et al. Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation. Virchows Arch. 2002 440 3 11.
10. Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int. J. Surg. Pathol. 2005 13 143 153.
11. Nagy GH, Frable WJ, Murphy WM. The classification of premalignant urothelial abnormalities. Pathol. Ann. 1982 17 219 233.
12. Murphy WM, Busch C, Algaba F. Intraepithelial lesions of the urinary bladder: morphologic considerations. Scand. J. Urol. Nephrol. 2000 205 67 81.
13. Murphy WM, Soloway MS. Urothelial dysplasia. J. Urol. 1982 127 849 854.
14. Zuk RJ, Rogers HS, Martin JE, Baithun SI. Clinicopathological importance of primary dysplasia of bladder. J. Clin. Pathol. 1988 41 1277 1280.
15. Cheng L, Cheville JC, Neumann RM, Bostwick DG. Natural history of urothelial dysplasia of the bladder. Am. J. Surg. Pathol. 1999 23 443 447.
16. Owens CL, Epstein JI. Significance of denuded urothelium in papillary urothelial lesions. Am. J. Surg. Pathol. 2007 31 298 303.
17. Harnden P, Eardley I, Joyce AD, Southgate J. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br. J. Urol. 1996 78 870 875.
18. Mallofré C, Castillo M, Morente V, Solé M. Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia. Mod. Pathol. 2003 16 187 191.
19. Desai S, Lim SD, Jimenez RE et al. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod. Pathol. 2000 13 1315 1323.
20. Kunju LP, Lee CT, Montie J, Shah RB. Utility of cytokeratin 20 and Ki-67 as markers of urothelial dysplasia. Pathol. Int. 2005 55 248 254.
21. McKenney JK, Amin MB. The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms. Semin. Diagn. Pathol. 2005 22 69 87.
22. McKenney JK, Desai S, Cohen C, Amin MB. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non neoplastic urothelium. An analysis of cytokeratin 20, p53, and CD44 antigens. Am. J. Surg. Pathol. 2001 25 1074 1078.
23. Parker DC, Folpe AL, Bell J et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am. J. Surg. Pathol. 2003 27 1 10.
24. Sarkis AS, Dalbagni G, Cordon-Cardo C et al. Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J. Urol. 1994 152 388 392.
25. Farrow GM, Utz DC. Observations on microinvasive transitional cell carcinoma of the urinary bladder. Clin. Oncol. 1982 1 609 615.
26. McKenney JK, Gomez JA, Desai S, Lee MW, Amin MB. Morphologic expressions of urothelial carcinoma in situ. A detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. Am. J. Surg. Pathol. 2001 25 356 362.
27. Farrow GM, Utz DC, Rife CC. Clinical observations on 69 cases of in situ carcinoma of the urinary bladder. Cancer Res. 1977 37 2794 2802.
28. Bostwick DG, Mikuz G. Urothelial papillary (exophytic) neoplasms. Virchows Arch. 2002 441 109 116.
29. Bostwick DG, Ramnani DM, Cheng L. Diagnosis and grading of bladder cancer and associated lesions. Urol. Clin. North Am. 1999 26 493 507.
30. Cheng L, Darson M, Cheville JC et al. Urothelial papilloma of the bladder: clinical and biologic implications. Cancer 1999 86 2098 2101.
31. Eble JN, Young RH. Benign and low grade papillary lesions of the urinary bladder: a review of the papilloma-papillary carcinoma controversy and a report of 5 typical papillomas. Semin. Diagn. Pathol. 1987 6 351 371.
32. McKenney JK, Amin MB, Young RH. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases. Mod. Pathol. 2003 16 623 629.
33. Alvarez-Kindelan J, Lopez-Beltran A, Anglada-Curado F et al. Clinico-pathologic differences between bladder neoplasms with low malignant potential and low-grade carcinomas. Actas Urol. Esp. 2001 25 645 650.
34. Campbell PA, Conrad RJ, Campbell CM, Nicol DL, MacTaggart P. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome. BJU Int. 2004 93 1228 1291.
35. Cheng L, Neumann RL, Bostwick DG. Papillary urothelial neoplasms of low malignant potential: clinical and biological implications. Cancer 1999 86 2102 2108.
36. Holmang S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J. Urol. 2001 165 1124 1128.
37. Malmstrom PU, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer: a retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. Scand. J. Urol. Nephrol. 1987 21 185 195.
38. Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Pauwels RP, Newling DW, ten Kate F. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J. Clin. Pathol. 2002 55 900 905.
39. Yin H, Leong AS-Y. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow up. Am. J. Clin. Pathol. 2004 121 679 687.
40. Lopez-Beltran A, Montironi R. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur. Urol. 2004 46 170 176.
41. Herr HW. Tumor progression and survival of patients with high-grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J. Urol. 2000 163 79 80.
42. Saika T, Tsushima T, Nasu Y et al. Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy. Jpn. J. Clin. Oncol. 2002 32 461 465.
43. Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG. Cancer heterogeneity and its biological implications in the grading of urothelial carcinoma. Cancer 2000 88 1663 1670.
44. Cina SJ, Lancaster-Weiss KJ, Lecksell K, Epstein JI. Correlation of Ki67 and p53 with the new World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasms. Arch. Pathol. Lab. Med. 2001 125 646 651.
45. Pich A, Chiusa L, Formiconi A, Galliano D, Bortolin P, Navone R. Biological differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinoma of the bladder. Am. J. Surg. Pathol. 2001 25 1528 1533.
46. Samaratunga H, Makarov DV, Epstein JI. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology 2002 60 315 319.
47. Fujii Y, Kawakami S, Koga F, Nemoto T, Kihara K. Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int. 2003 92 559 562.
48. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Busch C, Johansson SL. Recurrence and progression in low grade papillary urothelial tumors. J. Urol. 1999 162 702 707.
49. MacLennan GT, Kirkali Z, Cheng L. Histologic grading of noninvasive papillary urothelial neoplasms. Eur. Urol. 2007 51 889 898.
50. Melicow M, Hollowell J. Intra-urothelial cancer: carcinoma in situ, Bowen's disease of the urinary system. Discussion of 30 cases. J. Urol. 1952 68 763 771.
51. Volmar KE, Chan TY, De Marzo AM, Epstein JI. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma. Am. J. Surg. Pathol. 2003 27 1243 1252.
52. Humphrey PA. Urinary bladder pathology 2004: an update. Ann. Diagn. Pathol. 2004 6 380 389.
53. Cameron KM, Lupton CH. Inverted papilloma of the lower urinary tract. Br. J. Urol. 1976 48 567 577.
54. Cheng CW, Chan LW, Chan CK et al. Is surveillance necessary for inverted papilloma in the urinary bladder and urethra? ANZ J. Surg. 2005 75 213 217.
55. Amin MB, Gomez JA, Young RH. Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am. J. Surg. Pathol. 1997 21 1057 1068.
56. Cheng L, Leibovich BC, Cheville JC et al. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer 2000 88 1679 1686.
57. Bessette PL, Abell MR, Herwinig KR. A clinicopathologic study of squamous cell carcinoma of the bladder. J. Urol. 1974 112 66 67.
58. Guo CC, Fine SW, Epstein JI. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Am. J. Surg. Pathol. 2006 30 883 891.
59. Elem B, Alam SZ. Total intestinal metaplasia with focal adenocarcinoma in a schistosoma-infested defunctioned urinary bladder. Br. J. Urol. 1984 56 331 343.
60. Chan TY, Epstein JI. In situ adenocarcinoma of the bladder. Am. J. Surg. Pathol. 2001 25 892 899.
61. Corica FA, Husmann DA, Churchill BM et al. Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow up. Urology 1997 50 427 431.
62. Shaw JL, Gislason GJ, Imbriglia JE. Transition of cystitis glandularis to primary adenocarcinoma of the bladder. J. Urol. 1958 79 815.
63. Cheng L, Montironi R, Bostwick DG. Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am. J. Surg. Pathol. 1999 23 764 771.
64. Harnden P. A critical appraisal of the classification of the urothelial tumours: time for a review of the evidence and a radical change? BJU Int. 2007 99 723 725.
65. Lopez-Beltran A, Bassi PF, Pavone-Macaluso M, Montironi R. Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur. Urol. 2004 45 257 266.
66. Hensel DE, Jones JS. A critical appraisal of the classification of the urothelial tumours: time for a change but not the change proposed. BJU Int. 2007 100 1213 1214.